novo nordisk - Search News

News

Novo Nordisk ousts CEO

Reuters on MSN · 2h

Novo Nordisk ousts CEO after falling behind in weight loss market

Pedersen and Stine Jacobsen COPENHAGEN (Reuters) - Wegovy-maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday over concerns the company is losing its first-mover advantage in the highly competitive obesity drug market.

UPI on MSN · 6h

Novo Nordisk CEO will step down amid falling share price and 'recent market challenges'

Novo Nordisk CEO Lars Fruergaard Jorgensen is stepping down per mutual agreement with the company. The company said Friday he will continue as CEO for a while to smooth the leadership transition.

The New York Times · 7h

Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer.

2hon MSN

Novo Nordisk, U.S. biotech company team up to create obesity pills

Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...

8hon MSN

Talks to replace Novo Nordisk CEO lasted several weeks, board chair says

Discussions between Novo Nordisk and the Novo Nordisk Foundation that controls the company regarding a CEO change have been ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results